- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Xuanzhu Biopharmaceutical Co Ltd (2575)
Xuanzhu Biopharmaceutical Co Ltd stock price live, this page displays HK 2575 stock exchange data. View the 2575 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Xuanzhu Biopharmaceutical Co Ltd real time stock price chart below.
What Is the Xuanzhu Biopharmaceutical Co Ltd Stock Price Today?
The Xuanzhu Biopharmaceutical Co Ltd stock price today is 34.00.
What Is the Stock Symbol for Xuanzhu Biopharmaceutical Co Ltd?
The stock symbol for Xuanzhu Biopharmaceutical Co Ltd is ""2575.""
What Stock Exchange Does Xuanzhu Biopharmaceutical Co Ltd Trade On?
Xuanzhu Biopharmaceutical Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Xuanzhu Biopharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Xuanzhu Biopharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2575 quote. (ISIN: CNE1000074Q1)
What Is the Xuanzhu Biopharmaceutical Co Ltd Stock Price Today?
The Xuanzhu Biopharmaceutical Co Ltd stock price today is 34.00.
What Is the Stock Symbol for Xuanzhu Biopharmaceutical Co Ltd?
The stock symbol for Xuanzhu Biopharmaceutical Co Ltd is ""2575.""
What Stock Exchange Does Xuanzhu Biopharmaceutical Co Ltd Trade On?
Xuanzhu Biopharmaceutical Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Xuanzhu Biopharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Xuanzhu Biopharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 2575 quote. (ISIN: CNE1000074Q1)
Hong Kong
Currency in HKD
34.00
+0.10(+0.29%)
Closed·
Fair Value
An estimate of a Xuanzhu Biopharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.02
37.50
52 wk Range
23.82
37.50
Trading near 52-week High
1/2
Fair Value
An estimate of a Xuanzhu Biopharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.0237.50
52 wk Range
23.8237.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
2575 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Xuanzhu Biopharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Operates with a moderate level of debt
Xuanzhu Biopharmaceutical Co Ltd Company Profile
Xuanzhu Biopharmaceutical Co., Ltd. engages in the development, industrialization, and commercialization of small-molecule chemical drugs and macromolecular biopharmaceuticals in China. Its lead product candidates includes Core- KBP-3571 for the treatment of duodenum ulcers; XZP-3287, a CDK4/6 inhibitor for the treatment of HR+/HER2 advanced breast cancer; and and XZP-3621, a first-line treatment for patients with anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. The company also develops KM501, a first-in-class HER2/HER2 bispecific antibody drug conjugate, which is in Phase I clinical trial; KM602, which is in Phase I clinical trial for anti-tumor; XZP-7797, a selective and brain-penetrating poly ADP-ribose polymerase 1 inhibitor; and XZP-6924, a ubiquitin-specific protease 1 (USP1) inhibitor. In addition, it develops XZB-0004, an oral small molecule anexelekto inhibitor; XZP-6877, a DNA-dependent protein kinase inhibitor; NG-350A, a next-generation oncolytic viral therapy; XZP-5610, a non-steroid farnesoid X receptor; and XZP-6019, a first-in-class ketohexokinase (KHK) inhibitor. The company was founded in 2008 and is headquartered in Beijing, China. Xuanzhu Biopharmaceutical Co., Ltd. is a subsidiary of Sihuan Pharm.
Compare 2575 to Peers and Sector
Metrics to compare | 2575 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2575PeersSector | |
|---|---|---|---|---|
P/E Ratio | −29.0x | 18.6x | −0.7x | |
PEG Ratio | - | 0.03 | 0.00 | |
Price/Book | 19.1x | 2.9x | 2.6x | |
Price / LTM Sales | 505.5x | 3.8x | 3.4x | |
Upside (Analyst Target) | - | 11.3% | 39.1% | |
Fair Value Upside | Unlock | 9.2% | 5.3% | Unlock |
FAQ
What Stock Exchange Does Xuanzhu Biopharmaceutical Trade On?
Xuanzhu Biopharmaceutical is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Xuanzhu Biopharmaceutical?
The stock symbol for Xuanzhu Biopharmaceutical is "2575."
What Is Xuanzhu Biopharmaceutical's Earnings Per Share (TTM)?
The Xuanzhu Biopharmaceutical EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is 2575 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Xuanzhu Biopharmaceutical Stock Split?
Xuanzhu Biopharmaceutical has split 0 times.
How Many Employees Does Xuanzhu Biopharmaceutical Have?
Xuanzhu Biopharmaceutical has 197 employees.
What is the current trading status of Xuanzhu Biopharmaceutical (2575)?
As of 20 Oct 2025, Xuanzhu Biopharmaceutical (2575) is trading at a price of 34.00, with a previous close of 33.90. The stock has fluctuated within a day range of 31.02 to 37.50, while its 52-week range spans from 23.82 to 37.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.